Related Experiment Video
Updated: Jul 19, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft
M H Kamel1, P Mohan, P J Conlon
1Department of Urology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Pediatric Transplantation
|October 13, 2006
Summary
Rabbit antithymocyte globulin (RATG) therapy may reduce graft thrombosis in pediatric kidney transplants by decreasing platelet counts. This study found fewer thrombotic events in patients receiving RATG, suggesting a protective effect.
Area of Science:
- Nephrology
- Immunosuppression
- Pediatric Transplantation
Background:
- Graft thrombosis is a significant complication following pediatric renal transplantation.
- Understanding factors that mitigate this risk is crucial for improving graft survival.
Purpose of the Study:
- To evaluate the potential protective effect of rabbit antithymocyte globulin (RATG) therapy against graft vascular thrombosis in pediatric kidney transplant recipients.
- To assess the association between RATG-induced decrease in platelet count and the incidence of graft thrombosis.
Main Methods:
- A retrospective analysis of 120 pediatric kidney transplants performed between 1986 and 1998.
- Patients were divided into two groups: non-RATG (cyclosporine, azathioprine, steroids) and RATG (standard immunosuppression plus RATG).
- Platelet counts and graft thrombosis incidence were compared between groups.
Main Results:
- Six grafts (5%) experienced thrombosis, all occurring in the non-RATG group (p = 0.028).
- The RATG group showed a significantly greater median decrease in absolute platelet count at 1 and 3 days post-transplant compared to the non-RATG group (p ≤ 0.001).
- Multivariate analysis identified RATG use as a significant factor for reduced graft thrombosis risk (p = 0.044).
Conclusions:
- RATG therapy was associated with a significant decrease in platelet count post-transplantation.
- RATG use was linked to a lower incidence of graft thrombosis in pediatric renal transplant recipients.
- A potential role for RATG's effect on platelet count in preventing graft thrombosis is suggested.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...